AV
Atlas Venture Opportunity Fund I, LP
内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Atlas Venture Opportunity Fund I, LP. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. Cumulatively, 19 filings have been published. History available since 17 June 2026. The latest transaction was disclosed on 4 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Atlas Venture Opportunity Fund I, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
912 股@ US$79.37Common StockSEC144:0001628280-26-060746
2,810 股@ US$80.05Common StockSEC144:0001628280-26-060504
322,465 股@ US$25.960.17% mcap48.8% 占其流量CommonSEC144:0001628280-26-057191
63,643 股@ US$26.170.033% mcap19.0% 占其流量CommonSEC144:0001628280-26-056842
60,858 股@ US$22.840.035% mcap37.6% 占其流量CommonSEC144:0001628280-26-047534
100,019 股@ US$23.070.059% mcap62.4% 占其流量CommonSEC144:0001628280-26-047358
40,702 股@ US$20.940.017% mcap14.5% 占其流量CommonSEC144:0001628280-26-046093
10,473 股@ US$108.120.012% mcap14.4% 占其流量Common StockSEC144:0001628280-26-046098
64,411 股@ US$20.610.027% mcap22.7% 占其流量CommonSEC144:0001628280-26-045818
57,451 股@ US$116.460.069% mcap85.6% 占其流量Common StockSEC144:0001628280-26-045807
67,329 股@ US$99.870.069% mcap31.1% 占其流量Common StockSEC144:0001628280-26-045610
5,019 股@ US$20.330.0021% mcap1.5% 占其流量CommonSEC144:0001628280-26-045612
16,542 股@ US$98.250.017% mcap7.5% 占其流量Common StockSEC144:0001628280-26-045289
19,973 股@ US$20.260.0083% mcap5.8% 占其流量CommonSEC144:0001628280-26-045294
173 股@ US$99.450.0002% mcap0.1% 占其流量Common StockSEC144:0001628280-26-044985
30,774 股@ US$20.870.013% mcap9.2% 占其流量CommonSEC144:0001628280-26-044988
34,152 股@ US$90.430.031% mcap14.2% 占其流量Common StockSEC144:0001628280-26-044732
14,128 股@ US$89.900.013% mcap5.8% 占其流量Common StockSEC144:0001628280-26-044426
12,902 股@ US$87.440.011% mcap5.1% 占其流量Common StockSEC144:0001628280-26-044012
About Atlas Venture Opportunity Fund I, LP
Atlas Venture Opportunity Fund I, LP is a shareholder of Kymera Therapeutics, Inc. and Dyne Therapeutics, Inc. The declarant has 15 filings in total, and among the recent filings observed between 2026-06-17 and 2026-07-07, all are sales for a total of EUR 25193498, with the most frequent transaction nature being a notice of proposed sale (Form 144).